Stocks and Investing Stocks and Investing
Mon, May 16, 2022
Sun, May 15, 2022
Fri, May 13, 2022
Thu, May 12, 2022

Nathan Rich Maintained (AMRX) at Strong Buy with Decreased Target to $4.5 on, May 12th, 2022


Published on 2024-10-27 21:03:21 - WOPRAI
  Print publication without navigation


Nathan Rich of Goldman Sachs, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Strong Buy with Decreased Target from $6 to $4.5 on, May 12th, 2022.

Nathan, nor any peers, have made any analyst calls on AMRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30